XYL.NYSEXylem INC

Form 4: Xylem SVP McShane Boosts Stake, Exercises Options

Sentiment:

Insider Transaction Report


Xylem Inc.'s Senior Vice President and Chief Accounting Officer, Geri-Michelle McShane, reported acquisitions of common stock and stock options, alongside tax-related share dispositions.

Summary

  • Geri-Michelle McShane, SVP, CAO of Xylem Inc., reported multiple transactions involving Xylem common stock and non-qualified stock options.
  • Acquired 721 shares of common stock on March 1, 2026, upon vesting of performance-based stock units tied to Total Shareholder Return, priced at $128.98 per share.
  • Acquired 595 shares of common stock on March 1, 2026, upon vesting of performance-based stock units tied to Adjusted EBITDA, priced at $128.98 per share.
  • Acquired 405 shares of common stock on March 1, 2026, upon vesting of performance-based stock units tied to Revenue, priced at $128.98 per share.
  • Acquired 489 shares of common stock on March 1, 2026, upon vesting of performance-based stock units tied to ESG performance, priced at $128.98 per share.
  • Received an award of 616 restricted stock units on March 2, 2026, which are scheduled to vest in one-third increments on March 1, 2027, March 1, 2028, and March 1, 2029.
  • Disposed of a total of 992 shares of common stock on March 2, 2026, at $128.98 per share, to cover tax liabilities associated with the vesting of various stock units.
  • Received an award of 2,194 non-qualified stock options on March 2, 2026, with an exercise price of $128.98, which vest in one-third increments on March 1, 2027, March 1, 2028, and March 1, 2029, and expire on March 2, 2036.
  • Following these transactions, McShane beneficially owns 4,791 shares of common stock and 2,194 non-qualified stock options.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive filing, primarily because it confirms the achievement of various performance criteria leading to executive compensation, which reflects positively on the company's operational and strategic execution. The share dispositions are routine tax-related events.

Positives

  • Achievement of performance criteria (Total Shareholder Return, Adjusted EBITDA, Revenue, ESG performance) led to the vesting of performance-based stock units.
  • The reporting person received new awards of restricted stock units and non-qualified stock options, indicating continued incentive and alignment with company performance.
  • Transactions were made pursuant to a Rule 10b5-1(c) plan, suggesting pre-planned and automated trading, reducing concerns about opportunistic insider trading.

Negatives

  • A total of 992 shares of common stock were disposed of to cover tax liabilities, representing a reduction in direct share ownership.

Future Outlook

The filing indicates future vesting schedules for restricted stock units and non-qualified stock options, with one-third increments vesting on March 1, 2027, March 1, 2028, and March 1, 2029. The non-qualified stock options have an expiration date of March 2, 2036.

Industry Context

StockSavvy.ai notes that these transactions are routine executive compensation events, reflecting the company's established incentive plans and the achievement of performance targets. They do not inherently signal broader industry trends but rather internal corporate governance and compensation practices.

Comparison to Industry Standards

  • The use of performance-based stock units tied to metrics like Total Shareholder Return, Adjusted EBITDA, Revenue, and ESG performance aligns with common executive compensation practices in large publicly traded companies, similar to those seen at peers like Danaher Corporation or Roper Technologies, which also emphasize a mix of financial and strategic objectives in their incentive structures.
  • The structure of restricted stock units and non-qualified stock options with multi-year vesting schedules is a standard approach to executive retention and long-term alignment with shareholder interests, comparable to plans at companies such as Ecolab Inc. or Pentair plc in the water technology sector.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Executive Compensation PlanTransactions occurred under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), demonstrating the ongoing operation of the company's established executive compensation framework.February 24, 2016Reinforces the company's commitment to performance-based incentives and long-term alignment of executive interests with shareholder value.
Trading PlanTransactions were made pursuant to a Rule 10b5-1(c) plan, indicating a pre-arranged trading strategy.NAEnhances transparency and mitigates concerns about opportunistic insider trading by establishing a pre-determined schedule for stock transactions.

Stakeholder Impact

  • Shareholders: The achievement of performance criteria (TSR, Adjusted EBITDA, Revenue, ESG) for executive compensation suggests positive operational performance, which is beneficial for shareholders. The executive's increased stake (through options and net share acquisitions after tax) aligns their interests with long-term shareholder value.
  • Employees: The incentive plan structure provides a framework for performance-based compensation, potentially motivating other employees under similar plans.

Next Steps

  • Restricted stock units awarded on March 2, 2026, are scheduled to vest in one-third increments on March 1, 2027, March 1, 2028, and March 1, 2029.
  • Non-qualified stock options awarded on March 2, 2026, are scheduled to vest in one-third increments on March 1, 2027, March 1, 2028, and March 1, 2029.

Key Dates

DateDescription
February 24, 2016Date Xylem 2011 Omnibus Incentive Plan was Amended and Restated.
March 1, 2021Grant date for ESG performance-based stock units that vested on March 1, 2026.
March 1, 2023Grant date for performance-based stock units (TSR, Adjusted EBITDA, Revenue) that vested on March 1, 2026, and for some restricted stock units.
March 1, 2024Grant date for some restricted stock units.
March 1, 2026Vesting date for performance-based stock units tied to TSR, Adjusted EBITDA, Revenue, and ESG performance.
March 2, 2026Date of award for restricted stock units and non-qualified stock options, and date of share dispositions for tax liabilities.
March 3, 2026Signature date of the filing.
March 1, 2027First vesting increment for restricted stock units and non-qualified stock options awarded on March 2, 2026.
March 1, 2028Second vesting increment for restricted stock units and non-qualified stock options awarded on March 2, 2026.
March 1, 2029Third vesting increment for restricted stock units and non-qualified stock options awarded on March 2, 2026.
March 2, 2036Expiration date for non-qualified stock options awarded on March 2, 2026.

Recommendation

hold

This Form 4 filing details routine executive compensation events, including the vesting of performance-based stock units due to achieved company targets and the award of new long-term incentives. While the achievement of performance metrics is positive, the transactions are largely pre-planned and expected, including share dispositions for tax purposes. There is no new material information that would significantly alter the investment thesis for Xylem Inc., thus a 'hold' recommendation is appropriate as it reflects the status quo of ongoing executive compensation and performance.

Keywords

Xylem Inc., XYL, Form 4, Insider Trading, Stock Options, Restricted Stock Units, Performance-Based Stock Units, Executive Compensation, Geri-Michelle McShane, SVP CAO, Rule 10b5-1

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.